ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years
Xinlei Sun
Matched on ORCID iD 0009-0002-9835-8520; OpenAlex author ID A5062702757. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2023: 1 paper · 2024: 2 papers · 2025: 1 paper
Papers 4
- TREM2 Depletion in Pancreatic Cancer Elicits Pathogenic Inflammation and Accelerates Tumor Progression via Enriching IL-1β+ Macrophages. First author DOI 10.1053/j.gastro.2025.01.244↗
- Loss of p53 and SMAD4 induces adenosquamous subtype pancreatic cancer in the absence of an oncogenic KRAS mutation. First author DOI 10.1016/j.xcrm.2024.101711↗
- Genetic Deletion of Galectin-3 Inhibits Pancreatic Cancer Progression and Enhances the Efficacy of Immunotherapy. First author DOI 10.1053/j.gastro.2024.03.007↗
- Single-Cell Analysis Differentiates the Effects of p53 Mutation and p53 Loss on Cell Compositions of Oncogenic Kras-Driven Pancreatic Cancer. Co-author DOI 10.3390/cells12222614↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Daowei Yang · 4 shared papers, 2023–2025 · strength 1.01
- Paper Single-Cell Analysis Differentiates the Effects of p53 Mutation and p53 Loss on Cell Compositions of Oncogenic Kras-Dri… DOI 10.3390/cells12222614↗
- Paper TREM2 Depletion in Pancreatic Cancer Elicits Pathogenic Inflammation and Accelerates Tumor Progression via Enriching IL… DOI 10.1053/j.gastro.2025.01.244↗
- Paper Loss of p53 and SMAD4 induces adenosquamous subtype pancreatic cancer in the absence of an oncogenic KRAS mutation. DOI 10.1016/j.xcrm.2024.101711↗
- Yang Chen · 4 shared papers, 2023–2025 · strength 1.01
- Paper Single-Cell Analysis Differentiates the Effects of p53 Mutation and p53 Loss on Cell Compositions of Oncogenic Kras-Dri… DOI 10.3390/cells12222614↗
- Paper TREM2 Depletion in Pancreatic Cancer Elicits Pathogenic Inflammation and Accelerates Tumor Progression via Enriching IL… DOI 10.1053/j.gastro.2025.01.244↗
- Paper Loss of p53 and SMAD4 induces adenosquamous subtype pancreatic cancer in the absence of an oncogenic KRAS mutation. DOI 10.1016/j.xcrm.2024.101711↗
- Ignacio Ivan Wistuba Oyarzun · 3 shared papers, 2024–2025 · strength 0.70
- Paper TREM2 Depletion in Pancreatic Cancer Elicits Pathogenic Inflammation and Accelerates Tumor Progression via Enriching IL… DOI 10.1053/j.gastro.2025.01.244↗
- Paper Loss of p53 and SMAD4 induces adenosquamous subtype pancreatic cancer in the absence of an oncogenic KRAS mutation. DOI 10.1016/j.xcrm.2024.101711↗
- Paper Genetic Deletion of Galectin-3 Inhibits Pancreatic Cancer Progression and Enhances the Efficacy of Immunotherapy. DOI 10.1053/j.gastro.2024.03.007↗
- Anirban Maitra · 3 shared papers, 2024–2025 · strength 0.70
- Paper TREM2 Depletion in Pancreatic Cancer Elicits Pathogenic Inflammation and Accelerates Tumor Progression via Enriching IL… DOI 10.1053/j.gastro.2025.01.244↗
- Paper Loss of p53 and SMAD4 induces adenosquamous subtype pancreatic cancer in the absence of an oncogenic KRAS mutation. DOI 10.1016/j.xcrm.2024.101711↗
- Paper Genetic Deletion of Galectin-3 Inhibits Pancreatic Cancer Progression and Enhances the Efficacy of Immunotherapy. DOI 10.1053/j.gastro.2024.03.007↗
- Huamin Wang · 2 shared papers, 2024 · strength 0.42
- Paper Loss of p53 and SMAD4 induces adenosquamous subtype pancreatic cancer in the absence of an oncogenic KRAS mutation. DOI 10.1016/j.xcrm.2024.101711↗
- Paper Genetic Deletion of Galectin-3 Inhibits Pancreatic Cancer Progression and Enhances the Efficacy of Immunotherapy. DOI 10.1053/j.gastro.2024.03.007↗
- Hua Wang · 1 shared paper, 2024 · strength 0.21
- Hua Wang · 1 shared paper, 2024 · strength 0.21
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.